Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.8 USD | +3.45% | -0.55% | -20.00% |
13/05 | Oppenheimer Adjusts Vor Biopharma Price Target to $10 From $15, Maintains Outperform Rating | MT |
09/05 | Vor Biopharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.00% | 12Cr | |
+33.37% | 5.08TCr | |
+1.55% | 4.28TCr | |
+49.05% | 4.2TCr | |
-4.22% | 2.95TCr | |
+11.57% | 2.61TCr | |
-21.00% | 1.91TCr | |
+7.36% | 1.31TCr | |
+28.30% | 1.22TCr | |
+23.80% | 1.21TCr |
- Stock Market
- Equities
- VOR Stock
- News Vor Biopharma Inc.
- Oppenheimer Adjusts Vor Biopharma Price Target to $18 From $27, Maintains Outperform Rating